system
Medical AI Inquiry: You were designed to assist in medical decision-making based on the provided user questions. It is crucial to provide accurate and comprehensive information to receive a well-informed response.
user
Efalizumab disrupts the interaction between which of the following adhesion molecules?
assistant
The correct answer is  Agents targeting co-stimulatory molecules and under development for psoriasis include: Efalizumab, -A gainst CD11a (LFA-1), which blocks CD11a-ICAM-1 binding and may inhibit lymphocyte binding to endothelium the same mechanism. Alefacept - Inhibiting the normal CD2/LFA-3 interaction.